Literature DB >> 11590963

Norepinephrine and selective norepinephrine reuptake inhibitors in depression and mood disorders: their pivotal roles.

P Blier1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11590963      PMCID: PMC2553260     

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN: 1180-4882            Impact factor:   6.186


× No keyword cloud information.
  10 in total

1.  Vilazodone HCl (Viibryd): A Serotonin Partial Agonist and Reuptake Inhibitor For the Treatment of Major Depressive Disorder.

Authors:  Martin Paspe Cruz
Journal:  P T       Date:  2012-01

Review 2.  Of rodents and humans: A comparative review of the neurobehavioral effects of early life SSRI exposure in preclinical and clinical research.

Authors:  Matthew E Glover; Sarah M Clinton
Journal:  Int J Dev Neurosci       Date:  2016-05-07       Impact factor: 2.457

Review 3.  Regulation of monoamine transporters: Role of transporter phosphorylation.

Authors:  Sammanda Ramamoorthy; Toni S Shippenberg; Lankupalle D Jayanthi
Journal:  Pharmacol Ther       Date:  2010-10-15       Impact factor: 12.310

4.  Effects of acute treatment with paroxetine, citalopram and venlafaxine in vivo on noradrenaline and serotonin outflow: a microdialysis study in Swiss mice.

Authors:  D J P David; M Bourin; G Jego; C Przybylski; P Jolliet; A M Gardier
Journal:  Br J Pharmacol       Date:  2003-10-06       Impact factor: 8.739

5.  The involvement of noradrenergic mechanisms in the suppressive effects of diazepam on the hypothalamic-pituitary-adrenal axis activity in female rats.

Authors:  Dubravka Švob Štrac; Dorotea Muck-Šeler; Nela Pivac
Journal:  Croat Med J       Date:  2012-06       Impact factor: 1.351

6.  Antidepressant-Like Effect of Lipid Extract of Channa striatus in Postpartum Model of Depression in Rats.

Authors:  Mohamed Saleem Abdul Shukkoor; Mohamad Taufik Hidayat Bin Baharuldin; Abdul Manan Mat Jais; Mohamad Aris Mohamad Moklas; Sharida Fakurazi; Rusliza Basir
Journal:  Evid Based Complement Alternat Med       Date:  2017-11-29       Impact factor: 2.629

7.  Subcellular localization of the antidepressant-sensitive norepinephrine transporter.

Authors:  Heinrich J G Matthies; Qiao Han; Angela Shields; Jane Wright; Jessica L Moore; Danny G Winder; Aurelio Galli; Randy D Blakely
Journal:  BMC Neurosci       Date:  2009-06-23       Impact factor: 3.288

8.  Evidence for transcriptional factor dysregulation in the dorsal raphe nucleus of patients with major depressive disorder.

Authors:  Ilan A Kerman; René Bernard; William E Bunney; Edward G Jones; Alan F Schatzberg; Richard M Myers; Jack D Barchas; Huda Akil; Stanley J Watson; Robert C Thompson
Journal:  Front Neurosci       Date:  2012-10-18       Impact factor: 4.677

Review 9.  Modeling heritability of temperamental differences, stress reactivity, and risk for anxiety and depression: Relevance to research domain criteria (RDoC).

Authors:  Sarah M Clinton; Elizabeth A Shupe; Matthew E Glover; Keaton A Unroe; Chelsea R McCoy; Joshua L Cohen; Ilan A Kerman
Journal:  Eur J Neurosci       Date:  2021-03-24       Impact factor: 3.698

Review 10.  The Preclinical and Clinical Effects of Vilazodone for the Treatment of Major Depressive Disorder.

Authors:  Zeyad T Sahli; Pradeep Banerjee; Frank I Tarazi
Journal:  Expert Opin Drug Discov       Date:  2016-03-16       Impact factor: 6.098

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.